Skip to main content

Table 2 MTX intolerance development

From: Prediction of Methotrexate Intolerance in Juvenile Idiopathic Arthritis: a prospective, observational cohort study

Time point N Intolerance, n(%) a
3 months 140b 22 (15.7)
6 months 137b 33 (24.1)
12 months 129b 30 (23.3)
First treatment year 142 59 (41.5)
6 or 12 monthsd 152c 51 (33.6)
  1. Abbreviations: MTX, methotrexate; n, number of patients.
  2. aFrequencies are based on observed data; bPatients still on MTX; cCohort for prediction model construction; dOutcome was imputed in 21.7% of cases.
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096